Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2017, Article ID 2481021, 10 pages
Research Article

Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014

1Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Surgery, Firoozgar Clinical Research Development Center, Iran University of Medical Sciences, Tehran, Iran
3Department of Chemical Engineering and Applied Chemistry, Data Mining Research Group, University of Toronto, Toronto, ON, Canada
4Faculty of Management and Medical Information, Iran University of Medical Sciences, Tehran, Iran
5Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Correspondence should be addressed to Soheila Sayad; moc.oohay@aliehos.dayas

Received 20 June 2017; Revised 2 August 2017; Accepted 7 September 2017; Published 1 November 2017

Academic Editor: Peter A. Fasching

Copyright © 2017 Mohammad Esmaeil Akbari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. Breast cancer is the 5th leading cause of cancer death in Iranian women. This study analyzed 3010 women with breast cancer that had been referred to a cancer research center in Tehran between 1998 and 2014. Methods. In this retrospective study, we analyzed 3010 breast cancer cases with 32 clinical and paraclinical attributes. We checked the data quality rigorously and removed any invalid values or records. The method was data mining (problem definition, data preparation, data exploration, modeling, evaluation, and deployment). However, only the descriptive analyses’ results of the variables are presented in this article. To our knowledge, this is the most comprehensive study on breast cancer status in Iran. Results. A typical Iranian breast cancer patient has been a 40–50-year-old married woman with two children, who has a high school diploma and no history of abortion, smoking, or diabetes. Most patients were estrogen and progesterone receptor positive, human epidermal growth factor (HER) negative, and P53 negative. Most cases were detected in stage 2 with intermediate grade. Conclusion. This study revealed original findings which can be used in national policymaking to find the best early detection method and improve the care quality and breast cancer prevention in Iran.